Top Story

Iodinated contrast media are among the most commonly administered agents in radiology.
CT
Large Korean study adds evidence on contrast media hypersensitivity
A Korean study of almost 116,000 contrast media recipients adds new evidence on hypersensitivity risk factors, but a European expert says the findings should be interpreted in the context of current European practice.
Featured
Voxel-based morphometry (VBM) group comparison of grey matter brain volumes. TFCE-corrected significance map shown (one-tailed t-test; higher significance indicated by light blue color). (a) Comparison between ex-soccer players (n = 124) and controls (n = 40). (b) Comparison between ex-rugby players (n = 200) and controls (n = 33) from Graham & Zimmerman et al. (2025), reproduced with permission under Creative Commons license.
MRI
MRI shows higher neuro symptom burden for former football players
Surgeon performs a carotid artery procedure.
Interventional Radiology
German registry shows sharp rise in carotid artery stenting as CREST-2 reshapes prevention
Latest News
MRI false positive for additional disease, (top to bottom): A. Index lesion—grade 2 invasive ductal carcinoma; B. MRI lesion two, upper inner quadrant: Stromal sclerosis and columnar cell change; C. MRI lesion three, upper outer quadrant: No ultrasound correlate, no malignancy on follow-up; D. CEM marked background parenchymal enhancement with a unifocal retroareolar lesion demonstrating wash-out on delayed MLO. Images are republished under a Creative Commons license (CC BY 4.0).
CEM on par with MRI for breast cancer diagnosis, local staging
July 10, 2026
Cancer Target
New PET tracer show promise in neuroblastoma
July 9, 2026
Who's paying, and for what, is the question that actually decides whether AI in healthcare gets funded.
The cost of AI, and finding its breakeven point
July 9, 2026
Experts at the Royal College of Radiologists’ 2nd Annual Global AI Conference discussed how AI could help move cancer care toward more personalized treatment, from targeted radionuclide therapy dosing to drug discovery.
AI aims to decode targeted radiotherapy response
July 8, 2026
Cases of the Week
Check out our Cases of the Week!
40-year-old man undergoing x-ray after placement of pacemaker revisted
A 40-year-old man underwent a routine chest radiograph following placement of a cardiac pacemaker/ICD.
39-year-old man with orbital proptosis, possible orbital mass revisited
40-year-old man with right hip finding revisited
View All Cases
Iodinated contrast media are among the most commonly administered agents in radiology.
CT
Large Korean study adds evidence on contrast media hypersensitivity
MRI
MRI shows higher neuro symptom burden for former football players
Womens Imaging
CEM on par with MRI for breast cancer diagnosis, local staging
Molecular Imaging
New PET tracer show promise in neuroblastoma
Molecular Imaging
PET/MRI can reduce the need for biopsies in prostate cancer
Who's paying, and for what, is the question that actually decides whether AI in healthcare gets funded.
AI
The cost of AI, and finding its breakeven point
AI
AI aims to decode targeted radiotherapy response
AI
RCR: Agentic AI is off the leash, and already a workhorse for health systems
AI
Most patients want to know if AI being used for imaging reports
AI
More work than relief: AI in the wrong seat, RCR census finds
Nuclear Medicine Worker Sm
Industry News
Actineer completes Ra-226 recycling process to support Ac-225 supply
Ultrasound
HistoSonics gets CE Mark for histotripsy system
Industry News
Blue Earth, UCL dose first patient in Ac-225 PSMA prostate trial
Industry News
Philips launches new ultrasound system
Industry News
Imagion extends collaboration with Siemens on MRI contrast agent
More from AuntMinnieEurope
Actineer completes Ra-226 recycling process to support Ac-225 supply
By AuntMinnie.com staff writers
This process aims to improve Ac-225 supply predictability and cost stability, as well as reduce waste generation.
July 14, 2026
Nuclear Medicine Worker Sm
HistoSonics gets CE Mark for histotripsy system
By AuntMinnie.com staff writers
The system uses histotripsy, a noninvasive focused ultrasound technology that mechanically destroys liver tumors without surgery, needles, radiation, or heat.
July 13, 2026
Histosonics System (2) (1) (1)
Blue Earth, UCL dose first patient in Ac-225 PSMA prostate trial
By AuntMinnie.com staff writers
The study is evaluating an investigational alpha-emitting PSMA-targeted radiopharmaceutical in prostate cancer patients.
July 9, 2026
Blue Earth Therapeutics Logo
Philips launches new ultrasound system
By AuntMinnie.com staff writers
The system features AI-powered workflows and is designed for high-volume clinical environments.
July 8, 2026
Alturion
Imagion extends collaboration with Siemens on MRI contrast agent
By AuntMinnie.com staff writers
Siemens will provide in-kind expertise and technical support to clinical sites.
July 8, 2026
Ai Handshake
RCR: Agentic AI is off the leash, and already a workhorse for health systems
By Claudia Tschabuschnig
The technical crowd took the stage at the 2nd Annual Global AI Conference in London last week, to show radiologists where agentic AI is running, how it operates across a spread of autonomy, and why only the highest tiers demand serious governance.
July 7, 2026
Dr. Rowland Illing, chief medical officer at Amazon Web Services (AWS) and a former interventional radiologist.
Median gets CE marking for lung cancer screening software
By AuntMinnie.com staff writers
The CE marking follows the U.S. Food and Drug Administration (FDA)'s 510(k) clearance of eyonis LCS in February.
July 6, 2026
Lung Cancer
PET/MRI can reduce the need for biopsies in prostate cancer
By Will Morton
Prostate biopsies are associated with considerable morbidity, including pain, rectal bleeding, prostatitis, and urinary tract infections.
July 2, 2026
A visual abstract of the study.
Quibim launches AI breast MRI tool across Europe, UK
By AuntMinnieEurope.com staff writers
The tool, QP-Breast, highlights suspicious areas on MRI and generates reports from imaging findings.
July 2, 2026
Qp Breast Press 02
Imaging takes center stage in Europe's Safe Hearts Plan
By Claudia Tschabuschnig
Radiology and nuclear medicine are poised to play a central role in implementing the European Commission's Safe Hearts Plan, speakers said during a joint ESR/EANM event in Brussels.
July 2, 2026
The Safe Hearts Plan aims to shift healthcare systems toward prevention, earlier diagnosis, and more personalized care.
GE HealthCare, University Hospital Essen open nuclear medicine center
By AuntMinnieEurope.com staff writers
The center features the first installation of GE HealthCare's StarGuide GX SPECT/CT scanner.
July 1, 2026
Ge
Can side-chain chemistry help radiologists choose a safer contrast agent after a hypersensitivity reaction?
By Claudia Tschabuschnig
Choosing an alternative contrast agent after an allergic reaction often falls to clinical judgment. A new review examines whether side-chain chemistry can make that decision a little more evidence based.
July 1, 2026
Dr. Aart J. van der Molen, of Leiden University Medical Center in Leiden, the Netherlands, is the lead author of a review exploring side-chain chemistry as a guide for selecting alternative iodine-based contrast media.